UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways

Leukemia, 2021-01, Vol.35 (1), p.177-188

2021

Volltextzugriff (PDF)

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Blood, 2020-11, Vol.136 (20), p.2334-2345

2020

Volltextzugriff (PDF)

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

International journal of hematology, 2022-02, Vol.115 (2), p.233-243

2022

Volltextzugriff (PDF)

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8529-8539

2022

Volltextzugriff (PDF)

Overexpression of miR-669m inhibits erythroblast differentiation

Scientific reports, 2020-08, Vol.10 (1), p.13554-13554, Article 13554

2020

Volltextzugriff (PDF)

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Nature communications, 2024-02, Vol.15 (1), p.1367-1367, Article 1367

2024

Volltextzugriff (PDF)

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia

Annals of hematology, 2021-10, Vol.100 (10), p.2479-2486

2021

Volltextzugriff (PDF)

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

International journal of hematology, 2023-04, Vol.117 (4), p.553-562

2023

Volltextzugriff (PDF)

A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor

International journal of hematology, 2021-04, Vol.113 (4), p.606-610

2021

Volltextzugriff (PDF)

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-09, Vol.28 (9), p.1279-1285

2022

Volltextzugriff (PDF)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Journal of Clinical and Experimental Hematopathology, 2020, Vol.60(2), pp.60-61

2020

Volltextzugriff (PDF)

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report

Leukemia research reports, 2024, Vol.22, p.100478, Article 100478

2024

Volltextzugriff (PDF)

Chédiak–Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia

International journal of hematology, 2016-12, Vol.104 (6), p.637-638

2016

Volltextzugriff (PDF)

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia

International journal of hematology, 2017-12, Vol.106 (6), p.811-819

2017

Volltextzugriff (PDF)

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Journal of Clinical and Experimental Hematopathology, 2020, Vol.60(4), pp.159-168

2020

Volltextzugriff (PDF)

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

Cancer science, 2016-09, Vol.107 (9), p.1281-1289

2016

Volltextzugriff (PDF)

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

Blood cancer journal (New York), 2023-02, Vol.13 (1), p.23-23, Article 23

2023

Volltextzugriff (PDF)

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Journal of Clinical and Experimental Hematopathology, 2019, Vol.59(1), pp.34-39

2019

Volltextzugriff (PDF)

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma

Blood cancer discovery, 2021-07, Vol.2 (4), p.370-387

2021

Volltextzugriff (PDF)

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

International journal of hematology, 2016-03, Vol.103 (3), p.341-347

2016

Volltextzugriff (PDF)

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Leukemia research reports, 2016, Vol.5 (C), p.11-13

2016

Volltextzugriff (PDF)

Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.2081-2082

2022

Volltextzugriff (PDF)

Bilateral Hilar and Mediastinal Lymphadenopathy as an Initial Manifestation of Amyloidosis

The Tokai Journal of Experimental and Clinical Medicine, 2024, Vol.49 (1), p.12-16

2024

Volltextzugriff (PDF)

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies

Annals of hematology, 2022-09, Vol.101 (9), p.2013-2019

2022

Volltextzugriff (PDF)

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax

International journal of hematology, 2023-12, Vol.118 (6), p.711-717

2023

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(62)
Berichte
(2)

Sprache

Englisch
(56)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(25)
Humans
(23)
Hematology
(22)
Oncology
(18)
Medicine
(13)
Medicine & Public Health
(12)
Middle Aged
(10)
Female
(9)
Male
(9)
Aged
(8)
Multiple Myeloma
(8)
Adult
(7)
Aged, 80 And Over
(6)
Multiple Myeloma - Drug Therapy
(6)
Original Article
(6)
Case Report
(5)
Kinases
(5)
Leukemia
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

12 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

Overexpression of miR-669m inhibits erythroblast differentiation

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report

Chédiak–Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

Bilateral Hilar and Mediastinal Lymphadenopathy as an Initial Manifestation of Amyloidosis

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax

Suchergebnisse filtern